clindamycin

(redirected from Clindamycin palmitate hydrochloride)
Also found in: Dictionary, Wikipedia.

clindamycin

 [klin″dah-mi´sin]
1. a semisynthetic antibiotic that is a derivative of lincomycin; used to treat gram-positive penicillin-resistant infections.
2. a semisynthetic derivative of lincomycin used systemically, topically, and vaginally as an antibacterial, primarily against gram-positive bacteria; used also as the hydrochloride and phosphate salts and as the hydrochloride salt of the ester of clindamycin and palmitic acid (clindamycin palmitate hydrochloride).

clindamycin

/clin·da·my·cin/ (klin″dah-mi´sin) a semisynthetic derivative of lincomycin used systemically, topically, and vaginally as an antibacterial, primarily against gram-positive bacteria; used also as the hydrochloride and phosphate salts and as the hydrochloride salt of the ester of clindamycin and palmitic acid.

clindamycin

(klĭn′də-mī′sĭn)
n.
A semisynthetic antibiotic, C18H33ClN2O5S, derived from lincomycin and active against gram-positive bacteria.

clindamycin

Infectious disease An antibiotic combined with pyrimethamine to treat and prevent toxoplasmosis, PCP and, topically, for acne vulgaris Adverse effects Diarrhea, dysgeusia. See AIDS.

clindamycin

An antibiotic drug that penetrates well into bone to treat OSTEOMYELITIS. The drug is on the WHO official list. Brand names are Dalacin C and, for external use, Dalacin T.

clindamycin

macrolide; antibiotic agent effective against Gram-positive cocci, penicillin-resistant staphylococci (e.g. meticillin-resistant Staphylococcus aureus [MRSA]) and anaerobes; used to treat osteomyelitis and MRSA; it has serious side-effects (e.g. antibiotic-associated colitis)

clindamycin

a semisynthetic bacteriostatic antibiotic derivative of lincomycin with improved activity against anaerobic bacteria. It also has some antiprotozoal activity.